中华放射肿瘤学杂志
中華放射腫瘤學雜誌
중화방사종류학잡지
CHINESE JOURNAL OF RADIATION ONCOLOGY
2013年
3期
220-224
,共5页
宗井凤%潘建基%林少俊%陈韵彬%张瑜%徐鹭英%郑飞%郭巧娟%许元基
宗井鳳%潘建基%林少俊%陳韻彬%張瑜%徐鷺英%鄭飛%郭巧娟%許元基
종정봉%반건기%림소준%진운빈%장유%서로영%정비%곽교연%허원기
鼻咽肿瘤/放射疗法%磁共振成像%肿瘤分期
鼻嚥腫瘤/放射療法%磁共振成像%腫瘤分期
비인종류/방사요법%자공진성상%종류분기
Nasopharyngeal neoplasms/radiotherapy%Magnetic resonance imaging%Neoplasm staging
目的 探讨MRI发现的颅神经侵犯在鼻咽癌分期中意义.方法 回顾分析2005-2007年间基于MRI诊断的816例初诊鼻咽癌患者资料.T4期颅神经组定义为MRI上伴有颅神经侵犯但体检无颅神经麻痹且无其他T4期解剖结构侵犯者,余T4期患者定义为T4期其他组.临床分期中Ⅳa期颅神经组定义为T4期颅神经组N0~2期,余Ⅳa期患者定义为Ⅳa期其他组.比较T分期、临床分期各亚组疗后生存情况.Kaplan-Meier法计算生存率并用Logrank法检验.结果 随访率为94.1%.鼻咽癌颅神经侵犯率为38.5%.T分期中T2、T3、T4期颅神经组的无局部复发生存、无远处转移生存以及疾病相关生存曲线重合,但与T4期其他组能拉开.临床分期中Ⅳa期颅神经组5年疾病相关生存率与Ⅲ期的相似(x2 =0.18,P=0.674),而与Ⅱ、Ⅳa期其他组不同(x2=5.86、7.23,P=0.015、0.007).结论 MRI诊断颅神经侵犯的T4期、Ⅳa期患者,若无合并其他T4期解剖结构受累则无局部复发、无远处转移生存率与T2、T3期相似,疾病相关生存率与Ⅲ期相似,预后较T4期其他组及Ⅳa期其他组好;若将这部分患者归为T4期、Ⅳa期将导致患者接受适合于Ⅳ期病例的治疗方案从而引起过度治疗的可能.
目的 探討MRI髮現的顱神經侵犯在鼻嚥癌分期中意義.方法 迴顧分析2005-2007年間基于MRI診斷的816例初診鼻嚥癌患者資料.T4期顱神經組定義為MRI上伴有顱神經侵犯但體檢無顱神經痳痺且無其他T4期解剖結構侵犯者,餘T4期患者定義為T4期其他組.臨床分期中Ⅳa期顱神經組定義為T4期顱神經組N0~2期,餘Ⅳa期患者定義為Ⅳa期其他組.比較T分期、臨床分期各亞組療後生存情況.Kaplan-Meier法計算生存率併用Logrank法檢驗.結果 隨訪率為94.1%.鼻嚥癌顱神經侵犯率為38.5%.T分期中T2、T3、T4期顱神經組的無跼部複髮生存、無遠處轉移生存以及疾病相關生存麯線重閤,但與T4期其他組能拉開.臨床分期中Ⅳa期顱神經組5年疾病相關生存率與Ⅲ期的相似(x2 =0.18,P=0.674),而與Ⅱ、Ⅳa期其他組不同(x2=5.86、7.23,P=0.015、0.007).結論 MRI診斷顱神經侵犯的T4期、Ⅳa期患者,若無閤併其他T4期解剖結構受纍則無跼部複髮、無遠處轉移生存率與T2、T3期相似,疾病相關生存率與Ⅲ期相似,預後較T4期其他組及Ⅳa期其他組好;若將這部分患者歸為T4期、Ⅳa期將導緻患者接受適閤于Ⅳ期病例的治療方案從而引起過度治療的可能.
목적 탐토MRI발현적로신경침범재비인암분기중의의.방법 회고분석2005-2007년간기우MRI진단적816례초진비인암환자자료.T4기로신경조정의위MRI상반유로신경침범단체검무로신경마비차무기타T4기해부결구침범자,여T4기환자정의위T4기기타조.림상분기중Ⅳa기로신경조정의위T4기로신경조N0~2기,여Ⅳa기환자정의위Ⅳa기기타조.비교T분기、림상분기각아조료후생존정황.Kaplan-Meier법계산생존솔병용Logrank법검험.결과 수방솔위94.1%.비인암로신경침범솔위38.5%.T분기중T2、T3、T4기로신경조적무국부복발생존、무원처전이생존이급질병상관생존곡선중합,단여T4기기타조능랍개.림상분기중Ⅳa기로신경조5년질병상관생존솔여Ⅲ기적상사(x2 =0.18,P=0.674),이여Ⅱ、Ⅳa기기타조불동(x2=5.86、7.23,P=0.015、0.007).결론 MRI진단로신경침범적T4기、Ⅳa기환자,약무합병기타T4기해부결구수루칙무국부복발、무원처전이생존솔여T2、T3기상사,질병상관생존솔여Ⅲ기상사,예후교T4기기타조급Ⅳa기기타조호;약장저부분환자귀위T4기、Ⅳa기장도치환자접수괄합우Ⅳ기병례적치료방안종이인기과도치료적가능.
Objective To identify the value of cranial nerve involvement found on magnetic resonance imaging (MRI) in staging of nasopharyngeal carcinoma (NPC).Methods A retrospective analysis was performed on the clinical data of 816 patients with NPC initially diagnosed by MRI during 2005 -2007.The patients with stage T4 NPC were divided into cranial nerve subgroup,which was defined as patients who had cranial nerve involvement on MRI,but without cranial nerve palsy or other T4-related anatomical structure involvement,and other subgroup,which was defined as other patients with stage T4 NPC ;the patients with stage Ⅳ a NPC were divided into cranial nerve subgroup,which was defined as patients with T4N0-2 NPC who were classified into the cranial nerve subgroup of patients with stage T4 NPC,and other subgroup,which was defined as other patients with stage Ⅳa NPC.The survivals of the subgroups were compared.The Kaplan-Meier method was used for calculating survival rates,and the survival differences were analyzed by the log-rank test.Results The follow-up rate was 94.1%.Cranial nerve involvement was seen in 38.5% of all patients.Local recurrence-free survival,distant metastasis-free survival,and disease-related survival curves of patients with stage T2 and T3 NPC and the cranial nerve subgroup of patients with stage T4 NPC coincided,but they were separated from the curves of the other subgroup of patients with stage T4 NPC.There was no significant difference in 5-year disease-related survival rate between the cranial nerve subgroup of patients with stage Ⅳa NPC and the patients with stage Ⅲ NPC (x2 =0.18,P =0.674),but significant differences were found when this subgroup was compared with patients with stage Ⅱ NPC (x2 =5.86,P =0.015) and the other subgroup of patients with stage Ⅳa NPC (x2 =7.23,P =0.007).Conclusions The patients with stage T4/Ⅳa NPC who have cranial nerve involvement on MRI,but without other T4-related anatomical structure involvement,have similar local recurrence-free survival rate and distant metastasis-free survival rate as those with stage T2 and T3 NPC and have a similar disease-related survival rate as those with stage Ⅲ NPC,and their prognosis is better than that of the other subgroup of patients with stage T4/Ⅳa NPC.It may lead to overtreatment for patients if they are classified as stage T4/Ⅳa and receive the treatment regimen for stage Ⅳ NPC.